Lahey Medical Center Peabody 1 Essex Ctr Dr, Peabody, MA 01960 978 538-4000 (phone), 978 538-4712 (fax)
Lahey Health Outpatient General Surgery & Comprehensive Breast Health Center 41 Mall Rd, Burlington, MA 01805 781 744-8834 (phone), 781 744-5636 (fax)
Breast Health Center 480 Maple St, Danvers, MA 01923 978 304-8101 (phone), 978 304-8123 (fax)
Lahey Medical Center Peabody General Surgery & Breast Health Center 1 Essex Ctr Dr FL 3, Peabody, MA 01960 978 538-4250 (phone), 978 538-4720 (fax)
Education:
Medical School University of Maryland School of Medicine Graduated: 1993
Procedures:
Breast Biopsy Breast Reconstruction Mastectomy Thoracoscopy
Conditions:
Breast Disorders Malignant Neoplasm of Female Breast Benign Neoplasm of Breast Cholelethiasis or Cholecystitis Overweight and Obesity
Languages:
English
Description:
Dr. Yang graduated from the University of Maryland School of Medicine in 1993. She works in Danvers, MA and 4 other locations and specializes in General Surgery. Dr. Yang is affiliated with Beverly Hospital, Exeter Hospital, Lahey Hospital & Medical Center, Lahey Medical Center Peabody and Tufts Medical Center.
Private Tutor Jan 2013 to 2000Babysitter Aug 2009 to 2000Santa Clara Water Pollution Control Plant San Jose, CA Jun 2012 to Aug 2012 Summer InternSummer School Saratoga, CA Jun 2011 to Jul 2011 Cooking Class Teacher's Assistant
Conflicts Analyst (Business Intake & Risk Management)Hogan Lovells Washington, DC Aug 2013 to May 2014 Conflicts ResearcherLaw Offices of Triano Byrne San Francisco, CA 2011 to 2011 Legal Assistant/InternLaw Offices of Triano Byrne Pleasant Hill, CA 2011 to 2011 Italian Language TutorDiane Lee Neurology Albany, CA 2009 to 2010 SecretaryKathy Fang Dermatology Albany, CA 2008 to 2009 Receptionist
Education:
American University (AU), School of International Service Washington, DC 2011 to 2013 Bachelor of Arts in International StudiesContra Costa College San Pablo, CA 2009 to 2011 General StudiesDiablo Valley College Pleasant Hill, CA 2009 to 2011 Certificate in Language and Area Studies
Skills:
Legal and International research, Communication, Chinese and Italian language and researching skills, Elite database experience, New Business Intake and Special Projects work
Us Patents
Induction Of Antigen Specific Immunologic Tolerance
Emil D. Kakkis - Novato CA, US Merry Passage - Torrance CA, US Thomas Lester - Harbor City CA, US Rebecca Yang - Los Angeles CA, US Christopher Tanaka - Gardena CA, US
Assignee:
Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center - Torrance CA
International Classification:
A61K 45/00
US Classification:
4242781, 424 941
Abstract:
Antigen specific immune tolerance is induced in a mammalian host by administration of a toleragen in combination with a regimen of immunosuppression. The methods optionally include a preceding conditioning period, where immunosuppressive agents are administered in the absence of the toleragen. After the tolerizing regimen, the host is withdrawn from the suppressive agents, but is able to maintain specific immune tolerance to the immunogenic epitopes present on the toleragen. Optimally, the toleragen will have high uptake properties that allow uptake in vivo at low concentrations in a wide variety of tolerizing cell types.
Induction Of Antigen Specific Immunnologic Tolerance
Emil D. Kakkis - Novato CA, US Thomas Lester - Harbor City CA, US Merry Passage - Torrance CA, US Christopher Tanaka - Gardena CA, US Rebecca Yang - Los Angeles CA, US
International Classification:
A61K 39/385
US Classification:
4241931, 4241981
Abstract:
Antigen specific immune tolerance is induced in a mammalian host by administration of a toleragen in combination with a regimen of immunosuppression. The methods optionally include a preceding conditioning period, where immunosuppressive agents are administered in the absence of the toleragen. After the tolerizing regimen, the host is withdrawn from the suppressive agents, but is able to maintain specific immune tolerance to the immunogenic epitopes present on the toleragen. Optimally, the toleragen will have high uptake properties that allow uptake in vivo at low concentrations in a wide variety of tolerizing cell types.
Induction Of Antigen Specific Immunologic Tolerance
Emil Kakkis - Novato CA, US Thomas Lester - Harbor City CA, US Merry Passage - Torrance CA, US Christopher Tanaka - Gardena CA, US Rebecca Yang - Los Angeles CA, US
International Classification:
A61K038/13 A61K039/00
US Classification:
514/011000, 424/185100
Abstract:
Antigen specific immune tolerance is induced in a mammalian host by administration of a toleragen in combination with a regimen of immunosuppression. The methods optionally include a preceding conditioning period, where immunosuppressive agents are administered in the absence of the toleragen. After the tolerizing regimen, the host is withdrawn from the suppressive agents, but is able to maintain specific immune tolerance to the immunogenic epitopes present on the toleragen. Optimally, the toleragen will have high uptake properties that allow uptake in vivo at low concentrations in a wide variety of tolerizing cell types.
Induction Of Antigen Specific Immunologic Tolerance
Emil Kakkis - Novato CA, US Thomas Lester - Cardiff CA, US Merry Passage - Torrance CA, US Christopher Tanaka - Gardena CA, US Rebecca Yang - Los Angeles CA, US
International Classification:
A61K039/00 A61K038/13 A61K031/7024 A61K031/522
US Classification:
424184100, 514011000, 514263310, 514023000
Abstract:
Antigen specific immune tolerance is induced in a mammalian host by administration of a toleragen in combination with a regimen of immunosuppression. The methods optionally include a preceding conditioning period, where immunosuppressive agents are administered in the absence of the toleragen. After the tolerizing regimen, the host is withdrawn from the suppressive agents, but is able to maintain specific immune tolerance to the immunogenic epitopes present on the toleragen. Optimally, the toleragen will have high uptake properties that allow uptake in vivo at low concentrations in a wide variety of tolerizing cell types.